Jian Liu
Keine laufenden Positionen mehr
Karriereverlauf von Jian Liu
Ehemalige bekannte Positionen von Jian Liu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INNER MONGOLIA YITAI COAL CO.,LTD. | Direktor/Vorstandsmitglied | 11.03.2019 | 10.03.2023 |
| Vorstandsvorsitzender | 07.11.2019 | 10.03.2023 | |
| Vorsitzender | 11.03.2019 | 30.12.2019 | |
Inner Mongolia Yitai Pharmaceutical Co. Ltd.
 Inner Mongolia Yitai Pharmaceutical Co. Ltd. Pharmaceuticals: OtherHealth Technology Part of Zhejiang Conba Pharmaceutical Co., Ltd., Inner Mongolia Yitai Pharmaceutical Co. Ltd. is a company that manufactures and distributes Chinese medicine. The company is based in Ordos, China. Inner Mongolia Yitai Pharmaceutical Co. was acquired by Zhejiang Conba Pharmaceutical Co., Ltd. from Inner Mongolia Yitai Coal Co., Ltd. on September 05, 2012 for $31.41 million. | Corporate Officer/Principal | 01.08.2005 | 01.08.2012 |
Ausbildung von Jian Liu
| University of Duisburg-Essen | Doctorate Degree |
| Tsinghua University School of Economics & Management | Masters Business Admin |
Statistik
International
| China | 4 |
| Deutschland | 2 |
Operativ
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sektoral
| Consumer Services | 3 |
| Energy Minerals | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INNER MONGOLIA YITAI COAL CO.,LTD. | Energy Minerals |
| Private Unternehmen | 1 |
|---|---|
Inner Mongolia Yitai Pharmaceutical Co. Ltd.
Inner Mongolia Yitai Pharmaceutical Co. Ltd. Pharmaceuticals: OtherHealth Technology Part of Zhejiang Conba Pharmaceutical Co., Ltd., Inner Mongolia Yitai Pharmaceutical Co. Ltd. is a company that manufactures and distributes Chinese medicine. The company is based in Ordos, China. Inner Mongolia Yitai Pharmaceutical Co. was acquired by Zhejiang Conba Pharmaceutical Co., Ltd. from Inner Mongolia Yitai Coal Co., Ltd. on September 05, 2012 for $31.41 million. | Health Technology |
